It would be nice if the IE only give one valuation price the way many valuations are done, not this big range of almost 100% difference between high and low, and what about the 30% premium, Pfizer stated that they where paying us a 30% premium (as per norm in acquisitions) when the the price was at 0.09 cents making the price 11,5 cents, where was the premium at 14,6 cents.
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx, page-120
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)